Skip to content

ChirDigest: what changed

What changed

ChirDigest

BE 1011.887.667
NACE 86.220, Specialist medical practice
filed annual accounts (NBB)
Financial years compared with
Net result for the year
€31,326
2024 · €34,908-€3,583
Equity
€70,234
2024 · €38,908+€31,326
Cash
-
not filed
Balance sheet total
€95,122
2024 · €54,896+€40,226

Largest movements

2024 to 2025
Assets
  • Current investments +€49,862

    up €49,862 (+144%), from €34,665 to €84,527

  • Receivables within one year -€7,439

    down €7,439 (-41.2%), from €18,034 to €10,595

    of which Trade receivables: -€7,439

  • Deferred charges and accrued income -€1,437

    no longer reported in 2025 (was €1,437)

Equity and liabilities
  • Profit (loss) carried forward +€31,326

    up €31,326 (+89.7%), from €34,908 to €66,234

  • Tax, wage and social debts +€10,283

    up €10,283 (+73.2%), from €14,054 to €24,337

    of which Taxes: +€9,124

  • Trade debts -€1,794

    down €1,794 (-92.8%), from €1,934 to €140

Income statement
  • Taxes +€9,178

    up €9,178 (+100.0%), from €9,181 to €18,359

  • Gross operating margin +€5,799

    up €5,799 (+13.0%), from €44,705 to €50,504

Change in the result, 2024 to 2025

effect on the result

For each income-statement line you see the change as its effect on the result. Higher costs lower the result, higher income raises it.

Result 2024 €34,908
Gross operating margin +€5,799
Depreciation -€170
Financial income +€0
Financial charges -€34
Taxes -€9,178
Result 2025 €31,326
raises the resultlowers the result

Derived cash bridge

cash 2024 to 2025

Cash or the result is not a separate line in both sets of accounts. So the cash flow cannot be derived from them.

Every line side by side 31 lines
Line Code 2024 2025 Change %
Total assets 20/58 €54,896 €95,122 +€40,226 +73.3%
Formation expenses 20 €760 €0 -€760 -100%
Current assets 29/58 €54,136 €95,122 +€40,986 +75.7%
Amounts receivable within one year 40/41 €18,034 €10,595 -€7,439 -41.2%
Trade receivables 40 €17,963 €10,524 -€7,439 -41.4%
Other amounts receivable 41 €71 €71 = 0.0%
Current investments 50/53 €34,665 €84,527 +€49,862 +144%
Deferred charges and accrued income 490/1 €1,437 - -€1,437
Total equity and liabilities 10/49 €54,896 €95,122 +€40,226 +73.3%
Equity 10/15 €38,908 €70,234 +€31,326 +80.5%
Contributions 10/11 €4,000 €4,000 = 0.0%
Profit (loss) carried forward 14 €34,908 €66,234 +€31,326 +89.7%
Amounts payable 17/49 €15,988 €24,888 +€8,900 +55.7%
Amounts payable within one year 42/48 €15,988 €24,477 +€8,489 +53.1%
Trade debts 44 €1,934 €140 -€1,794 -92.8%
Suppliers 440/4 €1,934 €140 -€1,794 -92.8%
Taxes, remuneration and social security 45 €14,054 €24,337 +€10,283 +73.2%
Taxes 450/3 €11,938 €21,062 +€9,124 +76.4%
Remuneration and social security 454/9 €2,116 €3,274 +€1,159 +54.8%
Accrued charges and deferred income 492/3 - €411 +€411
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €590 €760 +€170 +28.8%
Gross operating margin 9900 €44,705 €50,504 +€5,799 +13.0%
Operating profit (loss) 9901 €44,115 €49,744 +€5,629 +12.8%
Financial income 75/76B - €0 +€0
Recurring financial income 75 - €0 +€0
Financial charges 65/66B €26 €60 +€34 +132%
Recurring financial charges 65 €26 €60 +€34 +132%
Profit (loss) for the period before taxes 9903 €44,089 €49,684 +€5,596 +12.7%
Income taxes 67/77 €9,181 €18,359 +€9,178 +100.0%
Profit (loss) for the period 9904 €34,908 €31,326 -€3,583 -10.3%
Profit (loss) for the period to be appropriated 9905 €34,908 €31,326 -€3,583 -10.3%
Calculation and sources

Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Green is a favourable move for that line, red an unfavourable one. Prepared on 7 November 2026 via checked.be.